Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
The defect of B cell development in CD19-Cre + PDK1 flox/flox mice is... | Download Scientific Diagram
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage | Leukemia
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
CD19 Monoclonal Antibody (eBio1D3 (1D3)), PerCP-Cyanine5.5 (45-0193-82)
Percentages of CD4 + IL10 + T cells and CD19 + IL10 + B cells increase,... | Download Scientific Diagram
Elevated peripheral blood B lymphocytes and CD3+CD4‑CD8‑ T lymphocytes in patients with non‑small cell lung cancer: A preliminary study on peripheral immune profile
Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia - Soma - 2015 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
CAR T Cell Immunotherapy Beyond Haematological Malignancy
Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies - ScienceDirect
Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
Cells | Free Full-Text | Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab | Haematologica
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies - ScienceDirect
Characteristics of iKP-19-CAR-T cells and CD19-CAR-T cells.... | Download Scientific Diagram
Antibodies | Free Full-Text | Cutaneous Lymphoma and Antibody-Directed Therapies
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response
Frontiers | Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
Normal B-cell ranges in infants: A systematic review and meta-analysis - ScienceDirect
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes | Science Advances
